110 related articles for article (PubMed ID: 15816544)
1. Progesterone induces BRCA1 mRNA decrease, cell cycle alterations and apoptosis in the MCF7 breast cancer cell line.
Ansquer Y; Legrand A; Bringuier AF; Vadrot N; Lardeux B; Mandelbrot L; Feldmann G
Anticancer Res; 2005; 25(1A):243-8. PubMed ID: 15816544
[TBL] [Abstract][Full Text] [Related]
2. [BRCA1 regulates progesterone receptors A and B protein expressions in breast cancer cells in vitro].
Guo YX; Zeng WS; Liu YW; Li YS; Lin J; Xiong JB; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1157-60. PubMed ID: 18676251
[TBL] [Abstract][Full Text] [Related]
3. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
[TBL] [Abstract][Full Text] [Related]
4. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
[TBL] [Abstract][Full Text] [Related]
6. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
Girgert R; Hanf V; Emons G; Gründker C
J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling revealed survivin as a target of 3,3'-diindolylmethane-induced cell growth inhibition and apoptosis in breast cancer cells.
Rahman KW; Li Y; Wang Z; Sarkar SH; Sarkar FH
Cancer Res; 2006 May; 66(9):4952-60. PubMed ID: 16651453
[TBL] [Abstract][Full Text] [Related]
8. Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis.
Yeung BH; Kwan BW; He QY; Lee AS; Liu J; Wong AS
Oncogene; 2008 Dec; 27(53):6782-9. PubMed ID: 18776923
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of BRCA1 protein in tumor breast tissue: prescreening of BRCA1 mutation in Tunisian patients with hereditary breast cancer?
Troudi W; Uhrhammer N; Ben Romdhane K; Sibille C; Mahfoudh W; Chouchane L; Ben Ayed F; Bignon YJ; Ben Ammar Elgaaied A
Eur J Histochem; 2007; 51(3):219-26. PubMed ID: 17921118
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine A inhibition of prolactin-dependent up-regulation of BRCA1 protein expression in human breast cell lines.
Favy DA; Rio PG; Vissac C; Maurizis JC; Bignon YJ; Bernard-Gallon DJ
Anticancer Res; 2000; 20(3A):1703-4. PubMed ID: 10928095
[TBL] [Abstract][Full Text] [Related]
11. Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers.
Toyama T; Yamashita H; Kondo N; Okuda K; Takahashi S; Sasaki H; Sugiura H; Iwase H; Fujii Y
BMC Cancer; 2008 Oct; 8():309. PubMed ID: 18950515
[TBL] [Abstract][Full Text] [Related]
12. Promotion of BRCA1-associated triple-negative breast cancer by ovarian hormones.
Lee EY
Curr Opin Obstet Gynecol; 2008 Feb; 20(1):68-73. PubMed ID: 18197009
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters.
Calvo V; Beato M
Cancer Res; 2011 May; 71(9):3422-31. PubMed ID: 21531767
[TBL] [Abstract][Full Text] [Related]
14. Elucidating progesterone effects in breast cancer: cross talk with PDGF signaling pathway in smooth muscle cell.
Soares R; Guerreiro S; Botelho M
J Cell Biochem; 2007 Jan; 100(1):174-83. PubMed ID: 16888808
[TBL] [Abstract][Full Text] [Related]
15. Prevention of Brca1-mediated mammary tumorigenesis in mice by a progesterone antagonist.
Poole AJ; Li Y; Kim Y; Lin SC; Lee WH; Lee EY
Science; 2006 Dec; 314(5804):1467-70. PubMed ID: 17138902
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer cell response to genistein is conditioned by BRCA1 mutations.
Privat M; Aubel C; Arnould S; Communal Y; Ferrara M; Bignon YJ
Biochem Biophys Res Commun; 2009 Feb; 379(3):785-9. PubMed ID: 19126406
[TBL] [Abstract][Full Text] [Related]
17. [BRCA1 inhibits progesterone-induced proliferation and migration of breast cancer cells].
Xiong J; Zhao J; Peng L; Wang H; Liang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Aug; 32(8):1105-10. PubMed ID: 22931600
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of proliferation and induction of apoptosis in human breast cancer cells by lauryl gallate.
Calcabrini A; García-Martínez JM; González L; Tendero MJ; Ortuño MT; Crateri P; Lopez-Rivas A; Arancia G; González-Porqué P; Martín-Pérez J
Carcinogenesis; 2006 Aug; 27(8):1699-712. PubMed ID: 16624827
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of telomerase activity after progesterone treatment of human breast cancer cells: essential role of the cell cycle status.
Lebeau J; Fouchet P; Ory K; Chevillard S
Anticancer Res; 2002; 22(4):2161-6. PubMed ID: 12174898
[TBL] [Abstract][Full Text] [Related]
20. Progesterone sensitizes breast cancer MCF7 cells to imatinib inhibitory effects.
Rocha A; Azevedo I; Soares R
J Cell Biochem; 2008 Feb; 103(2):607-14. PubMed ID: 17614352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]